ATE378351T1 - Therapeutische impfzusammensetzung zur verhütung und behandlung von erkrankungen bei säugetieren - Google Patents
Therapeutische impfzusammensetzung zur verhütung und behandlung von erkrankungen bei säugetierenInfo
- Publication number
- ATE378351T1 ATE378351T1 AT02785499T AT02785499T ATE378351T1 AT E378351 T1 ATE378351 T1 AT E378351T1 AT 02785499 T AT02785499 T AT 02785499T AT 02785499 T AT02785499 T AT 02785499T AT E378351 T1 ATE378351 T1 AT E378351T1
- Authority
- AT
- Austria
- Prior art keywords
- mammals
- preventing
- therapeutic vaccine
- vaccine composition
- treating diseases
- Prior art date
Links
- 241000124008 Mammalia Species 0.000 title abstract 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title abstract 2
- 229940021747 therapeutic vaccine Drugs 0.000 title abstract 2
- 201000010099 disease Diseases 0.000 title 1
- 125000003275 alpha amino acid group Chemical group 0.000 abstract 2
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 2
- 241000282421 Canidae Species 0.000 abstract 1
- 241000283086 Equidae Species 0.000 abstract 1
- 241000282323 Felidae Species 0.000 abstract 1
- 206010020751 Hypersensitivity Diseases 0.000 abstract 1
- 239000002671 adjuvant Substances 0.000 abstract 1
- 208000026935 allergic disease Diseases 0.000 abstract 1
- 210000004027 cell Anatomy 0.000 abstract 1
- 230000003111 delayed effect Effects 0.000 abstract 1
- 230000009610 hypersensitivity Effects 0.000 abstract 1
- 230000036039 immunity Effects 0.000 abstract 1
- 210000004698 lymphocyte Anatomy 0.000 abstract 1
- 230000001404 mediated effect Effects 0.000 abstract 1
- 230000001681 protective effect Effects 0.000 abstract 1
- 230000004044 response Effects 0.000 abstract 1
- 230000000638 stimulation Effects 0.000 abstract 1
- 229960005486 vaccine Drugs 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6854—Immunoglobulins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/5555—Muramyl dipeptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
- A61K2039/6031—Proteins
- A61K2039/6081—Albumin; Keyhole limpet haemocyanin [KLH]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biochemistry (AREA)
- Biomedical Technology (AREA)
- General Physics & Mathematics (AREA)
- Cell Biology (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Biophysics (AREA)
- Food Science & Technology (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Genetics & Genomics (AREA)
- Pathology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR0111942A FR2829767B1 (fr) | 2001-09-14 | 2001-09-14 | Composes peptidiques destines a la prevention et au traitement d'affections chez les mammiferes |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE378351T1 true ATE378351T1 (de) | 2007-11-15 |
Family
ID=8867311
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT02785499T ATE378351T1 (de) | 2001-09-14 | 2002-09-13 | Therapeutische impfzusammensetzung zur verhütung und behandlung von erkrankungen bei säugetieren |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20050079186A1 (de) |
| EP (1) | EP1425301B1 (de) |
| AT (1) | ATE378351T1 (de) |
| AU (1) | AU2002350800A1 (de) |
| DE (1) | DE60223564D1 (de) |
| ES (1) | ES2297025T3 (de) |
| FR (1) | FR2829767B1 (de) |
| WO (1) | WO2003025012A2 (de) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2842813B1 (fr) * | 2002-07-26 | 2007-06-01 | Bio Veto Tests Bvt | ANTICORPS D'ISOTYPES PARTICULIERS ANTI ANTIGENES D'EXCRETION SECRETION DE PROMASTIGOTES OU D'AMASTIGOTES DE Leishmania sp |
| FR2844511B1 (fr) * | 2001-09-14 | 2007-12-28 | Oridan Inc | Composes peptidiques destines a la prevention et au traitement d'affections chez les mammiferes |
| US7266395B2 (en) | 2003-10-30 | 2007-09-04 | Research In Motion Limited | System and method of wireless proximity awareness |
| FR2915397B1 (fr) * | 2007-04-27 | 2012-01-20 | Vincience | Composition pharmaceutique et/ou cosmetique contenant des principes actifs activateurs de l'aconitase |
| FR2932802B1 (fr) * | 2008-06-19 | 2010-08-20 | Oridan Inc | Peptide de synthese non natif cyclise et complexe de peptides comprenant ledit peptide cyclise, destine a induire et a caracteriser la prevention ou le traitement d'affections chez les mammiferes |
| BRPI0804859B1 (pt) * | 2008-08-22 | 2021-11-03 | Universidade Federal De Minas Gerais | Peptídeos sintéticos para a obtenção de polímero proteíco para imunização contra leishmaniose, produtos e seus usos |
| WO2012139094A2 (en) | 2011-04-08 | 2012-10-11 | H. Lee Moffitt Cancer Center And Research Institute, Inc. | Method of developing a vaccine using peptide-poly ic complexes |
| BR112013028891A2 (pt) | 2011-05-09 | 2018-04-24 | Laboratorios Leti S L | molécula para tratar um distúrbio inflamatório |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1997048725A1 (en) * | 1996-06-21 | 1997-12-24 | Peptech Limited | Novel peptides for prevention and treatment of infection |
-
2001
- 2001-09-14 FR FR0111942A patent/FR2829767B1/fr not_active Expired - Fee Related
-
2002
- 2002-09-13 US US10/489,586 patent/US20050079186A1/en not_active Abandoned
- 2002-09-13 DE DE60223564T patent/DE60223564D1/de not_active Expired - Lifetime
- 2002-09-13 ES ES02785499T patent/ES2297025T3/es not_active Expired - Lifetime
- 2002-09-13 AU AU2002350800A patent/AU2002350800A1/en not_active Abandoned
- 2002-09-13 AT AT02785499T patent/ATE378351T1/de not_active IP Right Cessation
- 2002-09-13 WO PCT/FR2002/003134 patent/WO2003025012A2/fr active IP Right Grant
- 2002-09-13 EP EP02785499A patent/EP1425301B1/de not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| EP1425301B1 (de) | 2007-11-14 |
| DE60223564D1 (de) | 2007-12-27 |
| US20050079186A1 (en) | 2005-04-14 |
| WO2003025012A2 (fr) | 2003-03-27 |
| ES2297025T3 (es) | 2008-05-01 |
| WO2003025012A3 (fr) | 2003-12-11 |
| EP1425301A2 (de) | 2004-06-09 |
| AU2002350800A1 (en) | 2003-04-01 |
| FR2829767B1 (fr) | 2004-02-27 |
| FR2829767A1 (fr) | 2003-03-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO933126D0 (no) | Loeselige ligander for cd40 | |
| ATE451119T1 (de) | Untereinheit-impfstoff gegen das respiratorische synzytialvirus | |
| WO2004030608A3 (en) | Nanoemulsion vaccines | |
| PT1409692E (pt) | Novos péptidos do derivados da proteína g do vírus respiratório sincicial (vrs) e sua utilização numa vacina | |
| HUP0301003A2 (hu) | Kazeinből származó peptidek és terápiás alkalmazásuk | |
| TR200002731T2 (tr) | Proteolitik antikorların indüktör ve inhibitörlerinin tanımlanması, kompozisyonları ve kullanımları için metotlar | |
| ATE547118T1 (de) | Rekombinanter koi-herpesvirus (khv) oder cyprinid-herpesvirus 3 (cyhv-3) und impfstoff zur prävention einer von khv/cyhv-3 bei cyprinus carpio carpio oder cyprinus carpio koi verursachten erkrankung | |
| WO2023094713A3 (en) | Coronavirus vaccine | |
| DE602006014720D1 (de) | Immunstimulatorische kombination zur vorbeugung und behandlung von hepatitis c | |
| HUP0500039A2 (hu) | Vakcina és eljárás mozgatóneuron-betegségek kezelésére | |
| ATE378351T1 (de) | Therapeutische impfzusammensetzung zur verhütung und behandlung von erkrankungen bei säugetieren | |
| WO2003059385A3 (en) | Hiv vaccine and method of use | |
| NO20051840L (no) | IHNV G-protein til immunstimulering. | |
| DE60313437D1 (de) | Mhc klasse i peptidepitope des humanen tumorassoziierten antigens 5t4 | |
| WO2004022092A3 (en) | Flagellin peptides as adjuvants for vaccines | |
| UA83989C2 (ru) | Выделенный пептид, который стимулирует противоопухолевый иммунный ответ, фармацевтическая композиция на его основе и ее применение | |
| DE60131975D1 (de) | Anwendung des herpes simplex virus glykoproteins-d zur unterdrückung von immunantworten | |
| ATE353226T1 (de) | Adjuvanszusammensetzung enthaltend fha oder ein fha-fragment in freier form | |
| ATE552269T1 (de) | Zykliertes, nichtnatives synthetisches peptid und peptidkomplex mit besagtem zykliertem peptid zur veranlassung und charakterisierung der vorbeugung oder behandlung von störungen bei säugetieren | |
| WO2003064446A3 (en) | Plasma protein-binding peptides from bacterial curli | |
| ATE145335T1 (de) | Kreuzreaktive immunisierung gegen influenza | |
| EP1467207A4 (de) | Screening-verfahren | |
| EA200400534A1 (ru) | Стимуляция тимозином генетической иммунизации | |
| ES2171360B1 (es) | Vacuna para la proteccion de animales frente a la leishmania. | |
| DE60036563D1 (de) | Nukleoprotein des toscanavirus |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |